CSIMarket
 
Nuo Therapeutics Inc   (NUOT)
 

Nuo Therapeutics Inc's Customers Performance

NUOT



 
NUOT's Source of Revenues During the corresponding time, Nuo Therapeutics Inc recorded a revenue increase by 168.82 % year on year, sequentially revenue grew by 30.05 %. While revenue at the Nuo Therapeutics Inc 's corporate clients

List of NUOT Customers




for the same period Nuo Therapeutics Inc recorded revenue increase by 168.82 % year on year, sequentially revenue grew by 30.05 %.

List of NUOT Customers

Nuo Therapeutics Inc's Business Units
Product    223.89 % of total Revenue
License    11.98 % of total Revenue
Aurix and Private Label Kits    212.44 % of total Revenue
Aurix and Private Label Centrifuge Devices    11.44 % of total Revenue
Single Reportable Segment    235.87 % of total Revenue






Nuo Therapeutics Inc's Comment on Sales, Marketing and Customers



The company serves wound care providers in private office settings and collaborates with hospitals and hospital systems to increase the use of POS 22. It has a Distribution Agreement with Smith+Nephew, a global medical technology company, under which the company supplies a private label version of its Aurix product for exclusive distribution by Smith+Nephew in the United States. Smith+Nephew purchases the private label product and distributes it to its customers. The company also markets, distributes, and sells its own Aurix branded product and maintains relationships with existing distributors and sales agents for Aurix. The Distribution Agreement includes minimum annual purchase commitments and fees related to reimbursement establishment and maintenance for both Aurix and the private label products.





Nuo Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company serves wound care providers in private office settings and collaborates with hospitals and hospital systems to increase the use of POS 22. It has a Distribution Agreement with Smith+Nephew, a global medical technology company, under which the company supplies a private label version of its Aurix product for exclusive distribution by Smith+Nephew in the United States. Smith+Nephew purchases the private label product and distributes it to its customers. The company also markets, distributes, and sells its own Aurix branded product and maintains relationships with existing distributors and sales agents for Aurix. The Distribution Agreement includes minimum annual purchase commitments and fees related to reimbursement establishment and maintenance for both Aurix and the private label products.








NUOT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Nuo Therapeutics Inc 0.00 4.04 -2.38 10
SUBTOTAL 0.00 0.00 0.00 -

Sources: Nuo Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Nuo Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Nuo Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.